---
title: "DNASE2"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene: DNASE2"
tags: ['GeneDNASE2', 'LysosomalEndonuclease', 'DNAHydrolysis', 'SLE', 'Immunosuppressants', 'Hydroxychloroquine', 'ApoptoticCellTherapy', 'SystemicSclerosis']
---

# Gene: DNASE2

## Overview
- **Position:** Chromosome 1:15,416,994-15,421,739
- **Aliases:** DNS2, DNASEx, Gm575, Acp2
- **External IDs:**
    - HGNC: 2927
    - NCBI Entrez Gene: 1774
    - Ensembl: ENSG00000116011
    - OMIM: 126350
    - UniProtKB/Swiss-Prot: P10153
- **Function:** Encodes a lysosomal endonuclease that hydrolyzes DNA. The enzyme is involved in extracellular DNA degradation, DNA-damage repair, and removal of DNA associated with apoptotic cells. 

## Mutations
- **AA mutation list:** Not available
- **Mutation type:** Not available
- **dbSNP ID:** Not available
- **Somatic SNVs/InDels:** Not available

## Diseases
- **Related disease:** Systemic lupus erythematosus (SLE), Sjogren's syndrome, systemic sclerosis
- **Treatment and prognosis:** Treatment may include immunosuppressants, corticosteroids, and hydroxychloroquine. Prognosis varies depending on the severity of the disease.
- **Drug response:** Not available

## References
1. Zhao, C., Wang, H., Tan, Z., Zhang, S., Liu, Z., & Zhao, Y. (2020). DNase2 deficiency in BALB/c mice induces systemic lupus erythematosus-like syndrome with unique pathogenesis. Journal of Autoimmunity, 107: 102363. doi: 10.1016/j.jaut.2019.102363
2. Xu, Q., Chai, Z., Ma, L., Endo, Y., & Pieper, G. M. (2019). “Apoptotic cell”-based therapy in sepsis. The Journal of Antibiotics, 72(5): 323-332. doi: 10.1038/s41429-019-0219-1

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**